Joseph Kovalchin - Concepedia

Author

Joseph Kovalchin

Also Known As

J T Kovalchin, J. Kovalchin, J.T. Kovalchin, Joseph Kovalchin, Joseph T Kovalchin, Joseph T. Kovalchin, Joseph T. Kovalchin, PhD, Joseph T. Kovalchin

Publications

771

Citations

H-Index

Concepts

All Affiliations

University of Connecticut UConn Health

About

Joseph Kovalchin is an author at University of Connecticut specializing in medicine, immunology, and inflammation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	151
2	Engineering	1	1	111
3	Natural Sciences	1	1	111
4	Biomolecular Engineering	1	1	111
5	Cell Biology	1	1	27

Joseph Kovalchin

Publications

722

Citations

H-Index

Page 1

	Year	Citations
Glycoprotein 96 Can Chaperone Both MHC Class I- and Class II-Restricted Epitopes for In Vivo Presentation, but Selectively Primes CD8+ T Cell Effector Function Amy D. H. Doody, Joseph Kovalchin, Marianne A. Mihalyo, The Journal of Immunology	2004	141
Crystal Structure of an HSA/FcRn Complex Reveals Recycling by Competitive Mimicry of HSA Ligands at a pH-Dependent Hydrophobic Interface Michael M. Schmidt, Sharon A. Townson, Amy Andreucci, Structure Crystal StructureEngineeringProtein AssemblyCompetitive MimicryNatural Sciences	2013	111
In vivo delivery of heat shock protein 70 accelerates wound healing by up‐regulating macrophage‐mediated phagocytosis Joseph Kovalchin, Ruibo Wang, Mihir S. Wagh, Wound Repair and Regeneration	2006	106
Exogenous heat shock protein 70 binds macrophage lipid raft microdomain and stimulates phagocytosis, processing, and MHC-II presentation of antigens Ruibo Wang, Joseph Kovalchin, Peggy Muhlenkamp, Blood	2005	104
Characterization of binding, functional activity, and contractile responses of the selective 5‐HT<sub>1F</sub> receptor agonist lasmiditan Eloísa Rubio‐Beltrán, Alejandro Labastida‐Ramírez, Kristian Agmund Haanes, British Journal of Pharmacology	2019	71
Design of a superior cytokine antagonist for topical ophthalmic use Jinzhao Hou, Sharon A. Townson, Joseph Kovalchin, Proceedings of the National Academy of Sciences Ocular DiseaseImmunologyImmune RegulationImmunologic MechanismInnate Immunity	2013	59
Determinants of efficacy of immunotherapy with tumor-derived heat shock protein gp96. Joseph Kovalchin, Ananth S. Murthy, Mark C. Horattas, PubMed ImmunologyPathologyImmune Cell TherapyImmunotherapyTumor Challenge	2001	35
In vivo treatment of mice with heat shock protein, gp96, improves survival of skin grafts with minor and major antigenic disparity Joseph Kovalchin, Clyde Mendonca, Mihir S. Wagh, Transplant Immunology Heat Shock ProteinXenotransplantationCutaneous BiologyImmunologyMajor Antigenic Disparity	2005	27
A Phase 2 Exploratory Study of a Novel Interleukin-1 Receptor Inhibitor (EBI-005) in the Treatment of Moderate-to-Severe Allergic Conjunctivitis Michael H. Goldstein, Karen L. Tubridy, Jennifer Agahigian, Eye & Contact Lens Science & Clinical Practice	2015	20
A phase I/II study on intracerebroventricular tralesinidase alfa in patients with Sanfilippo syndrome type B Nicole Muschol, Anja F. Koehn, Katharina von Cossel, Journal of Clinical Investigation Phase I/ii StudyClinical NeurologyNeurochemical BiomarkersPharmacotherapyTranslational Medicine	2022	19

Page 1